Neuland Laboratories Foglalás / Részvény
Mi az Neuland Laboratories Foglalás / Részvény?
A Foglalás / Részvény az Neuland Laboratories Limited - 574.19
Mi a Foglalás / Részvény meghatározása?
Az egy részvényre jutó könyv szerinti érték egy vállalat eszköze, mínusz kötelezettségek, osztva a fennálló részvények számával.
The book value of a company is the value of its assets according to its balance sheet account balance. For assets, the value is based on the original cost of the asset less any depreciation, amortization or impairment costs made against the asset. Traditionally, a company's book value is its total assets minus intangible assets and liabilities. However, in practice, depending on the source of the calculation, book value may variably include goodwill, intangible assets, or both. The value inherent in its workforce, part of the intellectual capital of a company, is always ignored. The book value of a company may be also referred as with the term net asset value.
The book value per share is the the balance sheet equity value divided by the number of shares outstanding at the date of the balance sheet. Book value per share can be used to generate a measure of comprehensive earnings, when the opening and closing values are reconciled. The sale of shares/units by a business increases the total book value. Book value per share will increase if the additional shares are issued at a price higher than the pre-existing book value per share. The purchase of its own shares by a business will decrease total book value. Book value per share will decrease if more is paid for them than was received when originally issued. Dividends paid out will decrease book value per share value.
Foglalás / Részvény a Health Care szektor a BSE-on cégekben a Neuland Laboratories -hoz képest
Mit csinál Neuland Laboratories?
Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. The company's APIs are used in various therapeutic areas, including antiasthmatics, cardiovasculars, antifungal, anticonvulsants, antiemetic, central nervous system, fluoroquinolones, corticosteroids, antipsychotic, antibacterial and anti-parkinson, anti-ulcerants, and prostaglandins. It also provides custom manufacturing solutions, as well as peptide synthesis services. The company was founded in 1984 and is headquartered in Hyderabad, India.
foglalás / részvény -hoz hasonló cégek Neuland Laboratories
- Oriental Carbon & Chemicals nak Foglalás / Részvény 571.23 van
- ACTIA S.A nak Foglalás / Részvény 571.99 van
- Shriram Pistons & Rings nak Foglalás / Részvény 572.08 van
- Gooch & Housego Plc nak Foglalás / Részvény 573.43 van
- Universal Cables nak Foglalás / Részvény 573.64 van
- Les Docks des Pétroles d'Ambès SA nak Foglalás / Részvény 573.79 van
- Neuland Laboratories nak Foglalás / Részvény 574.19 van
- BlackRock World Mining Trust Plc nak Foglalás / Részvény 574.28 van
- Rane nak Foglalás / Részvény 574.50 van
- Glenmark Pharmaceuticals nak Foglalás / Részvény 575.41 van
- Melrose Industries Plc nak Foglalás / Részvény 575.94 van
- Spandana Sphoorty nak Foglalás / Részvény 576.08 van
- Dishman Carbogen Amcis nak Foglalás / Részvény 576.21 van